Cytokinetics ROE - Return on Equity 2010-2024 | CYTK

Cytokinetics return on equity for the quarter ending September 30, 2024 was 335.95.

  • Cytokinetics average return on equity for 2023 was 341.61, a 166.99% decline from 2022.
  • Cytokinetics average return on equity for 2022 was -509.96, a 172.56% decline from 2021.
  • Cytokinetics average return on equity for 2021 was -187.1, a 68.79% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Cytokinetics ROE - Return on Equity 2010-2024 | CYTK

  • Cytokinetics average return on equity for 2023 was 341.61, a 166.99% decline from 2022.
  • Cytokinetics average return on equity for 2022 was -509.96, a 172.56% decline from 2021.
  • Cytokinetics average return on equity for 2021 was -187.1, a 68.79% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.